Ushering in a New Era of Sustainable Weight Loss with Incretin-Based Therapies (June 2021)

Ushering in a New Era of Sustainable Weight Loss with Incretin-Based Therapies (June 2021)

Monday, June 28, 2021
Webinar -- 6:45 PM ET
https://reg.cmrus.com/ada2021/

Agenda

6:45 PM Welcome and Program Overview

6:50 PM Regulations of Energy Balance and Incretin Therapies for Weight Management

     - Randy J. Seeley, PhD

7:10 PM Actions of Incretin-Based Therapies on Weight Loss and the Value of Sustained Weight Loss in Patients with Obesity and Related Comorbidities

     - Jenny Tong, MD, MPH

7:40 PM Current and Emerging Incretin-Based Drug Therapy for Long-term Weight Management

     - Kristina M. Utzschneider, MD

8:00 PM Question and Answer Session

     - Faculty Panel

8:15 PM Adjournment

Faculty

Faculty
Randy Seeley, PhD

Professor of Surgery
University of Michigan Department of Surgery
Director, Michigan Nutrition Obesity Research Center
Ann Arbor, MI

Faculty
Jenny Tong, MD, MPH

Associate Professor
Endocrine Section Head
VA Puget Sound Health System
Division of Metabolism, Endocrinology, and Nutrition
University of Washington
Seattle, WA

Faculty
Kristina Utzschneider, MD

Assistant Professor, Medicine
Division of Metabolism, Endocrinology and Nutrition
University of Washington
Director, VA Diabetes Care Program
VA Puget Sound Health Care System
Seattle, Washington

Goal Statement
The goals of this program are to improve clinician understanding of:

  • The metabolic adaptation in obesity
  • The value of sustained weight loss and related complications
  • The latest evidence for incretin-based therapies for long-term weight management

Target Audience
The live, virtual symposium is designed to meet the educational needs of endocrinologists (physicians and fellows), internists, primary care physicians, endocrine nurses, pharmacists, and other advanced practice professionals who will attend the American Diabetes Association’s Virtual 81st Scientific Sessions and care for individuals with obesity.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Examine the metabolic adaptations that contribute to weight loss challenges in patients with obesity
  • Describe the physiologic and metabolic effects of incretin-based therapies that lead to weight loss in patients with obesity and the benefits of sustained weight loss on obesity-related comorbidities
  • Summarize the long-term efficacy and safety data of current and emerging incretin-based therapies for the treatment of patients with obesity

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Psysicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-094-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.